<DOC>
	<DOCNO>NCT00929981</DOCNO>
	<brief_summary>This study prospective , non-interventional , single arm open label study , patient contact dermatitis require systemic steroid therapy purpose obtain real life effectiveness tolerability Medrol treat contact dermatitis Indian patient . Patients contact dermatitis prescribe Medrol enrol study follow resolution symptom</brief_summary>
	<brief_title>A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>To eligible enrollment study , patient must prescribe oral Medrol tablet ( 4mg 16 mg ) contact dermatitis per locally approve prescribe information Medrol tablets , prescribed patient physician accord his/her usual practice . The decision prescribe Medrol tablet necessarily precede independent decision enroll patient study Only patient , ready sign inform consent , include study Subject contact telephone Patients dermatological systemic condition may interfere confound study outcome measurement Patients take oral steroid preparation immunomodulators take oral medication last 15 day enrollment . NSAIDs ( Non Steroidal AntiInflammatory Agents ) exclude list Any contraindication Medrol tablet use . Contraindications Medrol use systemic fungal infection know hypersensitivity component Participation study within last 1 month current study begin and/or study participation Other severe acute chronic medical psychiatric condition laboratory abnormality may increase risk associate study participation investigational product administration may interfere interpretation study result , judgment investigator , would make subject inappropriate entry study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Contact Dermatitis</keyword>
	<keyword>Allergic Dermatitis</keyword>
</DOC>